QQ客服 官方微博 反馈留言

	A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.
	Ye, Xu; Li, Cunyan; Zu, Xuyu; Lin, Minglin; Liu, Qiang; Liu, Jianghua; Xu, Guoguo; Chen, Zhiyong; Xu, Yongliang; Liu, Long
刊名	Hepatology (Baltimore, Md.)
	2019
卷号	69期号:6页码:2489-2501
ISSN号	0270-9139
DOI	10.1002/hep.30519
URL标识	查看原文
WOS记录号	WOS:000470926600015
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5708822
专题	湖南中医药大学
作者单位	1.[Deng, Hongyu 2.Wang, J 3.Cao, Deliang 4.Liu, Qiang 5.Wang, Jing 6.Liao, Qianjin 7.Ye, Xu] Cent S Univ, Hunan Canc Hosp, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Ye, Xu,Li, Cunyan,Zu, Xuyu,et al. A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.[J]. Hepatology (Baltimore, Md.),2019,69(6):2489-2501.
APA	Ye, Xu.,Li, Cunyan.,Zu, Xuyu.,Lin, Minglin.,Liu, Qiang.,...&Cao, Deliang*.(2019).A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma..Hepatology (Baltimore, Md.),69(6),2489-2501.
MLA	Ye, Xu,et al."A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.".Hepatology (Baltimore, Md.) 69.6(2019):2489-2501.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。